aluates Reports

$ 0.0

Automative

Oral Live Cholera Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-5S616

Global Oral Live Cholera Vaccines Market Professional Survey Report 2019

BUY CHAPTERS

Oral Live Cholera Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5S616

Report

September 2024

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Valneva

PaxVax

Sanofi

EuBiologics

Shanghai United Cell Biotechnology

Vabiotech

Oral Live Cholera Vaccines - Market Size

The global market for Oral Live Cholera Vaccines was estimated to be worth US$ 85 million in 2023 and is forecast to a readjusted size of US$ 143.7 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030

Oral Live Cholera Vaccines - Market

Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.

Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Live Cholera Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Live Cholera Vaccines by region & country, by Type, and by Application.

The Oral Live Cholera Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Live Cholera Vaccines.

Market Segmentation

Scope of Oral Live Cholera Vaccines - Market Report

Report Metric	Details
Report Name	Oral Live Cholera Vaccines - Market
Forecasted market size in 2030	US$ 143.7 million
CAGR	7.0%
Forecasted years	2024 - 2030
Segment by Type:	Euvichol- Plus DUKORAL Shanchol Others
Segment by Application	Prevention Emergency Response
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PaxVax, Sanofi, Valneva, EuBiologics, Shanghai United Cell Biotechnology, Vabiotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oral Live Cholera Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oral Live Cholera Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Oral Live Cholera Vaccines - Market size in 2030?

Ans: The Oral Live Cholera Vaccines - Market size in 2030 will be US$ 143.7 million.

Who are the main players in the Oral Live Cholera Vaccines - Market report?

Ans: The main players in the Oral Live Cholera Vaccines - Market are PaxVax, Sanofi, Valneva, EuBiologics, Shanghai United Cell Biotechnology, Vabiotech

What are the Application segmentation covered in the Oral Live Cholera Vaccines - Market report?

Ans: The Applications covered in the Oral Live Cholera Vaccines - Market report are Prevention, Emergency Response

What are the Type segmentation covered in the Oral Live Cholera Vaccines - Market report?

Ans: The Types covered in the Oral Live Cholera Vaccines - Market report are Euvichol- Plus, DUKORAL, Shanchol, Others

Recommended Reports

Oral Vaccines Segment

Live Attenuated Vaccines

Diarrheal Disease Treatments

1 Market Overview

1.1 Oral Live Cholera Vaccines Product Introduction

1.2 Global Oral Live Cholera Vaccines Market Size Forecast

1.2.1 Global Oral Live Cholera Vaccines Sales Value (2019-2030)

1.2.2 Global Oral Live Cholera Vaccines Sales Volume (2019-2030)

1.2.3 Global Oral Live Cholera Vaccines Sales Price (2019-2030)

1.3 Oral Live Cholera Vaccines Market Trends & Drivers

1.3.1 Oral Live Cholera Vaccines Industry Trends

1.3.2 Oral Live Cholera Vaccines Market Drivers & Opportunity

1.3.3 Oral Live Cholera Vaccines Market Challenges

1.3.4 Oral Live Cholera Vaccines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Oral Live Cholera Vaccines Players Revenue Ranking (2023)

2.2 Global Oral Live Cholera Vaccines Revenue by Company (2019-2024)

2.3 Global Oral Live Cholera Vaccines Players Sales Volume Ranking (2023)

2.4 Global Oral Live Cholera Vaccines Sales Volume by Company Players (2019-2024)

2.5 Global Oral Live Cholera Vaccines Average Price by Company (2019-2024)

2.6 Key Manufacturers Oral Live Cholera Vaccines Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Oral Live Cholera Vaccines Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Oral Live Cholera Vaccines

2.9 Oral Live Cholera Vaccines Market Competitive Analysis

2.9.1 Oral Live Cholera Vaccines Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Oral Live Cholera Vaccines Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Live Cholera Vaccines as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Euvichol- Plus

3.1.2 DUKORAL

3.1.3 Shanchol

3.1.4 Others

3.2 Global Oral Live Cholera Vaccines Sales Value by Type

3.2.1 Global Oral Live Cholera Vaccines Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Oral Live Cholera Vaccines Sales Value, by Type (2019-2030)

3.2.3 Global Oral Live Cholera Vaccines Sales Value, by Type (%) (2019-2030)

3.3 Global Oral Live Cholera Vaccines Sales Volume by Type

3.3.1 Global Oral Live Cholera Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Oral Live Cholera Vaccines Sales Volume, by Type (2019-2030)

3.3.3 Global Oral Live Cholera Vaccines Sales Volume, by Type (%) (2019-2030)

3.4 Global Oral Live Cholera Vaccines Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Prevention

4.1.2 Emergency Response

4.2 Global Oral Live Cholera Vaccines Sales Value by Application

4.2.1 Global Oral Live Cholera Vaccines Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Oral Live Cholera Vaccines Sales Value, by Application (2019-2030)

4.2.3 Global Oral Live Cholera Vaccines Sales Value, by Application (%) (2019-2030)

4.3 Global Oral Live Cholera Vaccines Sales Volume by Application

4.3.1 Global Oral Live Cholera Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Oral Live Cholera Vaccines Sales Volume, by Application (2019-2030)

4.3.3 Global Oral Live Cholera Vaccines Sales Volume, by Application (%) (2019-2030)

4.4 Global Oral Live Cholera Vaccines Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Oral Live Cholera Vaccines Sales Value by Region

5.1.1 Global Oral Live Cholera Vaccines Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Oral Live Cholera Vaccines Sales Value by Region (2019-2024)

5.1.3 Global Oral Live Cholera Vaccines Sales Value by Region (2025-2030)

5.1.4 Global Oral Live Cholera Vaccines Sales Value by Region (%), (2019-2030)

5.2 Global Oral Live Cholera Vaccines Sales Volume by Region

5.2.1 Global Oral Live Cholera Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Oral Live Cholera Vaccines Sales Volume by Region (2019-2024)

5.2.3 Global Oral Live Cholera Vaccines Sales Volume by Region (2025-2030)

5.2.4 Global Oral Live Cholera Vaccines Sales Volume by Region (%), (2019-2030)

5.3 Global Oral Live Cholera Vaccines Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Oral Live Cholera Vaccines Sales Value, 2019-2030

5.4.2 North America Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Oral Live Cholera Vaccines Sales Value, 2019-2030

5.5.2 Europe Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Oral Live Cholera Vaccines Sales Value, 2019-2030

5.6.2 Asia Pacific Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Oral Live Cholera Vaccines Sales Value, 2019-2030

5.7.2 South America Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Oral Live Cholera Vaccines Sales Value, 2019-2030

5.8.2 Middle East & Africa Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Oral Live Cholera Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Oral Live Cholera Vaccines Sales Value

6.2.1 Key Countries/Regions Oral Live Cholera Vaccines Sales Value, 2019-2030

6.2.2 Key Countries/Regions Oral Live Cholera Vaccines Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Oral Live Cholera Vaccines Sales Value, 2019-2030

6.3.2 United States Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Oral Live Cholera Vaccines Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Oral Live Cholera Vaccines Sales Value, 2019-2030

6.4.2 Europe Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Oral Live Cholera Vaccines Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Oral Live Cholera Vaccines Sales Value, 2019-2030

6.5.2 China Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

6.5.3 China Oral Live Cholera Vaccines Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Oral Live Cholera Vaccines Sales Value, 2019-2030

6.6.2 Japan Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Oral Live Cholera Vaccines Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Oral Live Cholera Vaccines Sales Value, 2019-2030

6.7.2 South Korea Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Oral Live Cholera Vaccines Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Oral Live Cholera Vaccines Sales Value, 2019-2030

6.8.2 Southeast Asia Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Oral Live Cholera Vaccines Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Oral Live Cholera Vaccines Sales Value, 2019-2030

6.9.2 India Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

6.9.3 India Oral Live Cholera Vaccines Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 PaxVax

7.1.1 PaxVax Company Information

7.1.2 PaxVax Introduction and Business Overview

7.1.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.1.4 PaxVax Oral Live Cholera Vaccines Product Offerings

7.1.5 PaxVax Recent Development

7.2 Sanofi

7.2.1 Sanofi Company Information

7.2.2 Sanofi Introduction and Business Overview

7.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sanofi Oral Live Cholera Vaccines Product Offerings

7.2.5 Sanofi Recent Development

7.3 Valneva

7.3.1 Valneva Company Information

7.3.2 Valneva Introduction and Business Overview

7.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Valneva Oral Live Cholera Vaccines Product Offerings

7.3.5 Valneva Recent Development

7.4 EuBiologics

7.4.1 EuBiologics Company Information

7.4.2 EuBiologics Introduction and Business Overview

7.4.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.4.4 EuBiologics Oral Live Cholera Vaccines Product Offerings

7.4.5 EuBiologics Recent Development

7.5 Shanghai United Cell Biotechnology

7.5.1 Shanghai United Cell Biotechnology Company Information

7.5.2 Shanghai United Cell Biotechnology Introduction and Business Overview

7.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Offerings

7.5.5 Shanghai United Cell Biotechnology Recent Development

7.6 Vabiotech

7.6.1 Vabiotech Company Information

7.6.2 Vabiotech Introduction and Business Overview

7.6.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Vabiotech Oral Live Cholera Vaccines Product Offerings

7.6.5 Vabiotech Recent Development

8 Industry Chain Analysis

8.1 Oral Live Cholera Vaccines Industrial Chain

8.2 Oral Live Cholera Vaccines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Oral Live Cholera Vaccines Sales Model

8.5.2 Sales Channel

8.5.3 Oral Live Cholera Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Valneva

PaxVax

Sanofi

EuBiologics

Shanghai United Cell Biotechnology

Vabiotech

List of Tables

Table 1. Oral Live Cholera Vaccines Market Trends

Table 2. Oral Live Cholera Vaccines Market Drivers & Opportunity

Table 3. Oral Live Cholera Vaccines Market Challenges

Table 4. Oral Live Cholera Vaccines Market Restraints

Table 5. Global Oral Live Cholera Vaccines Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Oral Live Cholera Vaccines Revenue Market Share by Company (2019-2024)

Table 7. Global Oral Live Cholera Vaccines Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Oral Live Cholera Vaccines Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Oral Live Cholera Vaccines Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Oral Live Cholera Vaccines Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Oral Live Cholera Vaccines Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Oral Live Cholera Vaccines

Table 13. Global Oral Live Cholera Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Live Cholera Vaccines as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Live Cholera Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Oral Live Cholera Vaccines Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Oral Live Cholera Vaccines Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Oral Live Cholera Vaccines Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Oral Live Cholera Vaccines Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Oral Live Cholera Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Oral Live Cholera Vaccines Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Oral Live Cholera Vaccines Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Oral Live Cholera Vaccines Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Oral Live Cholera Vaccines Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Oral Live Cholera Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Oral Live Cholera Vaccines Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Oral Live Cholera Vaccines Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Oral Live Cholera Vaccines Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Oral Live Cholera Vaccines Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Oral Live Cholera Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Oral Live Cholera Vaccines Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Oral Live Cholera Vaccines Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Oral Live Cholera Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Oral Live Cholera Vaccines Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Oral Live Cholera Vaccines Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Oral Live Cholera Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Oral Live Cholera Vaccines Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Oral Live Cholera Vaccines Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Oral Live Cholera Vaccines Sales Value by Region (2019-2024) & (%)

Table 44. Global Oral Live Cholera Vaccines Sales Value by Region (2025-2030) & (%)

Table 45. Global Oral Live Cholera Vaccines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Oral Live Cholera Vaccines Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Oral Live Cholera Vaccines Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Oral Live Cholera Vaccines Sales Volume by Region (2019-2024) & (%)

Table 49. Global Oral Live Cholera Vaccines Sales Volume by Region (2025-2030) & (%)

Table 50. Global Oral Live Cholera Vaccines Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Oral Live Cholera Vaccines Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Oral Live Cholera Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Oral Live Cholera Vaccines Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Oral Live Cholera Vaccines Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Oral Live Cholera Vaccines Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Oral Live Cholera Vaccines Sales Volume, (2025-2030) & (K Units)

Table 57. PaxVax Company Information

Table 58. PaxVax Introduction and Business Overview

Table 59. PaxVax Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. PaxVax Oral Live Cholera Vaccines Product Offerings

Table 61. PaxVax Recent Development

Table 62. Sanofi Company Information

Table 63. Sanofi Introduction and Business Overview

Table 64. Sanofi Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Sanofi Oral Live Cholera Vaccines Product Offerings

Table 66. Sanofi Recent Development

Table 67. Valneva Company Information

Table 68. Valneva Introduction and Business Overview

Table 69. Valneva Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Valneva Oral Live Cholera Vaccines Product Offerings

Table 71. Valneva Recent Development

Table 72. EuBiologics Company Information

Table 73. EuBiologics Introduction and Business Overview

Table 74. EuBiologics Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. EuBiologics Oral Live Cholera Vaccines Product Offerings

Table 76. EuBiologics Recent Development

Table 77. Shanghai United Cell Biotechnology Company Information

Table 78. Shanghai United Cell Biotechnology Introduction and Business Overview

Table 79. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Offerings

Table 81. Shanghai United Cell Biotechnology Recent Development

Table 82. Vabiotech Company Information

Table 83. Vabiotech Introduction and Business Overview

Table 84. Vabiotech Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Vabiotech Oral Live Cholera Vaccines Product Offerings

Table 86. Vabiotech Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Oral Live Cholera Vaccines Downstream Customers

Table 90. Oral Live Cholera Vaccines Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Live Cholera Vaccines Product Picture

Figure 2. Global Oral Live Cholera Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Oral Live Cholera Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Oral Live Cholera Vaccines Sales Volume (2019-2030) & (K Units)

Figure 5. Global Oral Live Cholera Vaccines Sales Price (2019-2030) & (USD/Unit)

Figure 6. Oral Live Cholera Vaccines Report Years Considered

Figure 7. Global Oral Live Cholera Vaccines Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Oral Live Cholera Vaccines Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Live Cholera Vaccines Revenue in 2023

Figure 10. Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Euvichol- Plus Picture

Figure 12. DUKORAL Picture

Figure 13. Shanchol Picture

Figure 14. Others Picture

Figure 15. Global Oral Live Cholera Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Oral Live Cholera Vaccines Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Oral Live Cholera Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Oral Live Cholera Vaccines Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Oral Live Cholera Vaccines Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Prevention

Figure 21. Product Picture of Emergency Response

Figure 22. Global Oral Live Cholera Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Oral Live Cholera Vaccines Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Oral Live Cholera Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Oral Live Cholera Vaccines Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Oral Live Cholera Vaccines Price by Application (2019-2030) & (USD/Unit)

Figure 27. North America Oral Live Cholera Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Oral Live Cholera Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Oral Live Cholera Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Oral Live Cholera Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Oral Live Cholera Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Oral Live Cholera Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Oral Live Cholera Vaccines Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Oral Live Cholera Vaccines Sales Volume (%), (2019-2030)

Figure 39. United States Oral Live Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Oral Live Cholera Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Oral Live Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Oral Live Cholera Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 45. China Oral Live Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 47. China Oral Live Cholera Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Oral Live Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Oral Live Cholera Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Oral Live Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Oral Live Cholera Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Oral Live Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Oral Live Cholera Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 57. India Oral Live Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Oral Live Cholera Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 59. India Oral Live Cholera Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 60. Oral Live Cholera Vaccines Industrial Chain

Figure 61. Oral Live Cholera Vaccines Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Cholera Vaccine Market Research Report 2025

Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Orally Administered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Live Attenuated Rotavirus Vaccine Market Research Report 2024

Oral Vaccine for Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hog Cholera Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccines for Aquatic Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Delivery Vaccines Market Research Report 2025

Therapeutic Proteins and Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Vaccines Administered Orally Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cholera Treatment Market Research Report 2024

Global Human Oral Vaccine Market Research Report 2024

Global Live Attenuated Rotavirus Vaccine Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions